v3.25.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Cost of Goods and Service
Purchases
Supplier B
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023     30,773,000        
Beginning balance at Dec. 31, 2023 $ 101,960   $ 3 $ (34,504) $ 463,140 $ 127 $ (326,806)
Beginning balance (in shares) at Dec. 31, 2023       1,109,000      
Increase (Decrease) in Equity              
Net income 3,536           3,536
Foreign currency translation adjustment 58         58  
Stock issued under employee stock purchase plan (in shares)       (19,000)      
Stock issued under employee stock purchase plan 62       62    
Restricted stock granted (in shares)     94,000        
Stock compensation expense $ 642       642    
Shares withheld to cover taxes (in shares) 6,000     6,000      
Shares withheld to cover taxes $ (24)     $ (24)      
Restricted stock forfeited (in shares)       11,000      
Ending balance (in shares) at Jun. 30, 2024     30,867,000        
Ending balance at Jun. 30, 2024 106,234   $ 3 $ (34,528) 463,844 185 (323,270)
Ending balance (in shares) at Jun. 30, 2024       1,107,000      
Increase (Decrease) in Equity              
Expenditure   $ 4,103          
Total spend (in percentage)   8.00%          
Beginning balance (in shares) at Mar. 31, 2024     30,773,000        
Beginning balance at Mar. 31, 2024 103,898   $ 3 $ (34,514) 463,484 169 (325,244)
Beginning balance (in shares) at Mar. 31, 2024       1,112,000      
Increase (Decrease) in Equity              
Net income 1,974           1,974
Foreign currency translation adjustment 16         16  
Stock issued under employee stock purchase plan (in shares)       (9,000)      
Stock issued under employee stock purchase plan 28       28    
Restricted stock granted (in shares)     94,000        
Stock compensation expense $ 332       332    
Shares withheld to cover taxes (in shares) 4,000     4,000      
Shares withheld to cover taxes $ (14)     $ (14)      
Ending balance (in shares) at Jun. 30, 2024     30,867,000        
Ending balance at Jun. 30, 2024 $ 106,234   $ 3 $ (34,528) 463,844 185 (323,270)
Ending balance (in shares) at Jun. 30, 2024       1,107,000      
Increase (Decrease) in Equity              
Expenditure   $ 4,103          
Total spend (in percentage)   16.00%          
Beginning balance (in shares) at Dec. 31, 2024 30,938,073   30,938,000        
Beginning balance at Dec. 31, 2024 $ 113,900   $ 3 $ (34,666) 464,620 251 (316,308)
Beginning balance (in shares) at Dec. 31, 2024 1,111,565     1,112,000      
Increase (Decrease) in Equity              
Net income $ 7,148           7,148
Foreign currency translation adjustment (155)         (155)  
Stock issued under option exercises (in shares)     2,000        
Stock issued under option exercises 8       8    
Stock issued under employee stock purchase plan (in shares)       (9,000)      
Stock issued under employee stock purchase plan 68       68    
Restricted stock granted (in shares)     26,000        
Stock compensation expense $ 1,137       1,137    
Shares withheld to cover taxes (in shares) 8,000     8,000      
Shares withheld to cover taxes $ (60)     $ (60)      
Excess consideration over historical asset book value (Note 3) (92,400)       (92,400)    
Restricted stock forfeited (in shares)       3,000      
Restricted stock units vested (in shares)     3,000        
Issuance of April 2025 Warrant, net (Note 3) $ 42,204       42,204    
Ending balance (in shares) at Jun. 30, 2025 30,968,827   30,969,000        
Ending balance at Jun. 30, 2025 $ 71,850   $ 3 $ (34,726) 415,637 96 (309,160)
Ending balance (in shares) at Jun. 30, 2025 1,114,387     1,114,000      
Increase (Decrease) in Equity              
Total spend (in percentage)   16.00%          
Beginning balance (in shares) at Mar. 31, 2025     30,941,000        
Beginning balance at Mar. 31, 2025 $ 119,704   $ 3 $ (34,689) 465,112 206 (310,928)
Beginning balance (in shares) at Mar. 31, 2025       1,114,000      
Increase (Decrease) in Equity              
Net income 1,768           1,768
Foreign currency translation adjustment (110)         (110)  
Stock issued under option exercises (in shares)     2,000        
Stock issued under option exercises 8       8    
Stock issued under employee stock purchase plan (in shares)       (5,000)      
Stock issued under employee stock purchase plan 37       37    
Restricted stock granted (in shares)     26,000        
Stock compensation expense $ 676       676    
Shares withheld to cover taxes (in shares) 5,000     5,000      
Shares withheld to cover taxes $ (37)     $ (37)      
Excess consideration over historical asset book value (Note 3) (92,400)       (92,400)    
Issuance of April 2025 Warrant, net (Note 3) $ 42,204       42,204    
Ending balance (in shares) at Jun. 30, 2025 30,968,827   30,969,000        
Ending balance at Jun. 30, 2025 $ 71,850   $ 3 $ (34,726) $ 415,637 $ 96 $ (309,160)
Ending balance (in shares) at Jun. 30, 2025 1,114,387     1,114,000      
Increase (Decrease) in Equity              
Expenditure   $ 6,171          
Total spend (in percentage)   19.00%